UnitedHealth Group Incorporated $UNH Shares Sold by Wedmont Private Capital

Wedmont Private Capital reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,029 shares of the healthcare conglomerate’s stock after selling 1,067 shares during the period. Wedmont Private Capital’s holdings in UnitedHealth Group were worth $3,341,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the first quarter worth approximately $42,000. Copia Wealth Management acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $42,000. Finally, O Brien Wealth Partners LLC raised its holdings in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after buying an additional 37 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE UNH opened at $341.46 on Thursday. The stock’s 50-day moving average price is $294.30 and its two-hundred day moving average price is $367.06. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market cap of $309.25 billion, a PE ratio of 14.79, a PEG ratio of 2.22 and a beta of 0.45. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Oppenheimer cut their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Finally, Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.